Genetics


NEWS AND ADVANCES IN BRIEF

By Shoshana Olidort

When clinical trials began two years ago for treatment of Late Onset Tay-Sachs with the drug Zavesca, the trial was scheduled to last one year, with a possible 12-month extension. But because LOTS is such a rare disease, with only 200 known cases nationwide, researchers at New York University’s School of Medicine and the University Hospital ofRead More


Drug May Prolong Lives of Tay-Sachs Babies

By Shoshana Olidort

For the first time ever, infants with Tay-Sachs disease may have a fighting chance at prolonging their lives.In July, the pharmaceutical company Actelion approved a contract for clinical trials of the drug Zavesca for treatment of infants with Tay-Sachs disease. The proposal marks the first clinical trial ever to involve infants suffering from theRead More


NYU Move To Offer 16 Tests Ups the Ante for Screening

By Talia Bloch

In September, New York University Medical Center will become the first medical facility in the country to offer Ashkenazic Jewish couples tests for 16 inheritable genetic diseases, an expansion from the nine tests it offered until a year ago. Welcomed by some in the medical community as an advance in patient care, the move is prompting others toRead More


Mixed-heritage Family Deals With Genetic Tragedy

By Shoshana Olidort

When Rachaeli Fier uttered her first word — abba, or father — her parents had no idea it would be her last. Rachaeli was born a perfect baby girl, a “designer baby,” as the hospital’s delivery staff called her. Now, Eric and Nicole Fier watch helplessly as Rachaeli spirals downward in rapid, steady regression. Two-and-a-half-year-oldRead More


Breast Cancer Test Patent Causing a Furor

By Karen Iris Tucker

An American firm’s new European patent on a screening test for a genetic mutation that causes breast cancer has created an uproar among geneticists in Israel and Europe, who say the patent raises ethical questions because it targets Ashkenazic Jews.The firm, Myriad Genetics, of Salt Lake City, Utah, was granted the EuropeanRead More


Zebrafish Provide Key to Unlocking Secrets of Fanconi Anemia

By Mark I. Levenstein

The zebrafish, an inch-long fish indigenous to the Ganges River in East India and Burma, is proving to be a useful animal for understanding Fanconi Anemia.Drs. John Postlethwait and Tom Titus of the University of Oregon’s Institute of Neuroscience told the Forward that they have almost completed mapping the protein sequence of the lastRead More


Gene Found for Dystonia-related Disorder

By Mordechai Shinefield

Scientists have unlocked the gene responsible for a rare and debilitating genetic disorder.Rapid-onset dystonia-parkinsonism, or RDP, is a rare genetic disorder whose sufferers share symptoms with both dystonia and Parkinson’s disease. In an article published in the July 21 issue of the neuroscience journal Neuron, a research team detailed itsRead More


Cord Blood Transplants Eyed As Therapy for Some Diseases

By E.B. Solomont

In a medical development with potentially far-reaching effects, researchers have transplanted cord blood into newborns with a rare genetic disease, preserving their brain development and performing a life-saving treatment for babies with a fatal genetic disorder.Scientists from Duke University Medical Center and the University of North Carolina atRead More


Scientists Seek New Crohn’s Treatments

By Mordechai Shinefield

Researchers are exploring two possible new treatments — one in trials, the other still speculative — for Crohn’s disease, a genetically linked digestive-tract disorder suffered by an estimated 500,000 Americans, mostly Jews of Ashkenazic descent.Discovered by Dr. Burrill Crohn in 1932, Crohn’s, which is similar toRead More


Supplements Holding Hope As Treatment For Canavan

By E.B. Solomont

New research indicates that acetate supplements may be an effective therapy for Canavan disease, a degenerative and ultimately fatal disorder of the brain and central nervous system.Currently, there is no cure for Canavan disease, a recessive genetic disorder that is carried by one in 40 Ashkenazic Jews. Canavan patients have a mutation of theRead More





Find us on Facebook!
  • Vinyl isn't just for hipsters and hippies. Israeli photographer Eilan Paz documents the most astonishing record collections from around the world:http://jd.fo/g3IyM
  • Could Spider-Man be Jewish? Andrew Garfield thinks so.
  • Most tasteless video ever? A new video shows Jesus Christ dying at Auschwitz.
  • "It’s the smell that hits me first — musty, almost sweet, emanating from the green felt that cradles each piece of silver cutlery in its own place." Only one week left to submit! Tell us the story of your family's Jewish heirloom.
  • Mazel tov to Chelsea Clinton and Marc Mezvinsky!
  • If it's true, it's pretty terrifying news.
  • “My mom went to cook at the White House and all I got was this tiny piece of leftover raspberry ganache."
  • Planning on catching "Fading Gigolo" this weekend? Read our review.
  • A new initiative will spend $300 million a year towards strengthening Israel's relationship with the Diaspora. http://jd.fo/q3Iaj Is this money spent wisely?
  • Lusia Horowitz left pre-state Israel to fight fascism in Spain — and wound up being captured by the Nazis and sent to die at Auschwitz. Share her remarkable story — told in her letters.
  • Vered Guttman doesn't usually get nervous about cooking for 20 people, even for Passover. But last night was a bit different. She was cooking for the Obamas at the White House Seder.
  • A grumpy Jewish grandfather is wary of his granddaughter's celebrating Easter with the in-laws. But the Seesaw says it might just make her appreciate Judaism more. What do you think?
  • “Twist and Shout.” “Under the Boardwalk.” “Brown-Eyed Girl.” What do these great songs have in common? A forgotten Jewish songwriter. We tracked him down.
  • What can we learn from tragedies like the rampage in suburban Kansas City? For one thing, we must keep our eyes on the real threats that we as Jews face.
  • from-cache

Would you like to receive updates about new stories?




















We will not share your e-mail address or other personal information.

Already subscribed? Manage your subscription.